Advances in oto-immunology: new trends in functional pathology of the temporal bone.
By using monoclonal and polyclonal antibodies against cell-membrane receptors and cytoskeletal proteins, the cellular and tissue composition of any organ can be far better determined. This is illustrated in the tympanic membrane, middle ear mucosa, and cholesteatoma. Immunotechnology applied to the temporal bone is shown with an animal-ototoxicity model. Antibodies to keratin and vimentin (i.e., to proteins of the fibrillar components that make up the cytoskeleton) stain specific tissue compartments. Langerhans' cell and T-lymphocyte subsets predominate in a cholesteatoma. The normal human tympanic membrane is devoid of these cells. Gentamicin can be traced with a polyvalent anti-gentamicin antiserum in serial sections of the cochlea and kidney. The drug accumulates in the outer hair cells and proximal tubular cells, respectively. A new technique of CT-scanning, microslicing, plastic embedding, and semithin sectioning of undecalcified human temporal bone is described. Perspectives in applying immunotechnology to this method of human temporal bone processing are discussed.
D000818:Animals; D002781:Cholesteatoma / Q000473:pathology; D003051:Cochlea / Q000032:analysis; D004427:Ear Diseases / Q000378:metabolism / Q000473:pathology; D007758:Ear, Inner / Q000187:drug effects; D004432:Ear, Middle / Q000473:pathology; D005839:Gentamicins / Q000032:analysis / Q000494:pharmacology; D006168:Guinea Pigs; D006801:Humans; D007124:Immunoenzyme Techniques; D013701:Temporal Bone / Q000000981:diagnostic imaging / Q000473:pathology*; D014057:Tomography, X-Ray Computed; D014432:Tympanic Membrane / Q000473:pathology
D005839:Gentamicins